Publication date: Available online 1 June 2018
Source:Seminars in Oncology
Author(s): Antonio Tito Fojo
The current double issue of Seminars in Oncology brings 11 contributions from the Center for Genetic Engineering and Biotechnology, the Center of Molecular Immunology, and the Center of Medical and Surgical Research in Cuba. Having left Cuba in 1960, my interest in these submissions admittedly could go beyond the merely scientific. But others, I guarantee, will find EVERY article remarkably interesting and informative. In an era where the overwhelming majority of therapies in development as well as clinical trials being conducted are following well-traveled paths that bring us limited new information, the investigators from Cuba present us with rational, novel approaches to drug development. This is truly out of the box thinking, crafted in a country where resource limitations have clearly incentivized novel approaches. Their basic science is solid and their clinical validation is either mature or a work very much in progress. Cancer, one realizes reading these contributions, is a scourge across the world. Enjoy the refreshing and exciting approach of these investigators!!!
https://ift.tt/2Hcfw5C
Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,00306932607174,alsfakia@gmail.com,
Ετικέτες
Παρασκευή 1 Ιουνίου 2018
Cuba Si. Cancer No.
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
-
Summary Insulinomas are rare neuroendocrine tumours that classically present with fasting hypoglycaemia. This case report discusses an un...
-
The online platform for Taylor & Francis Online content New for Canadian Journal of Remote Sen...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου